Michel J. Shami, MD

Areas of Focus  |  Vitreoretinal Surgery, Medical Retina, Director of Clinical Research – Texas Retina Associates, Lubbock

Office Locations  |  Lubbock

Languages Spoken  |  English, French, Arabic

“The greatest reward of all is to meet the expectations of a trusting patient and restore sight.”

Fellowship

Vitreoretinal Diseases
and Surgery
California Pacific
Medical Center
San Francisco, California

Vitreoretinal Diseases
and Surgery
Department of Ophthalmology
and Visual Sciences
Texas Tech University Health Sciences Center
Lubbock, Texas

Residency

Ophthalmology
American University Hospital
Beirut, Lebanon

Internship

Internal Medicine
American University Hospital
Beirut, Lebanon

Medical School

American University of Beirut
Beirut, Lebanon

Professional Affiliations / Memberships

  • American Academy of Ophthalmology
  • American Society of Retina Specialists
  • Texas Medical Association

Research Interests / Experience

  • Diabetic Retinopathy Clinical Research Network
  • Co-investigator: Age-Related Eye Disease Study (AREDS 2) study, National Eye Institute, 2006-2013. Results published in JAMA.2013;309(19):2005-15 and JAMA Ophthalmol.7376, published online December 5, 2013.
  • Co-investigator: Effect of Ozurdex (Dexamethasone Intravitreal Implant) 0.7 MG on Improvement of Efficacy of Bevacizumab Therapy for Non-Ischemic CRVO. TRA-OZAB-11-001.
  • Principal Investigator: The Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study, National Eye Institute and Emmes Corporation 2004 – 2009.
  • Principal investigator. An Open-label, Multi-center, Safety Study of the Treatment of Predominantly Classic Subfoveal Choroidal Neovascularization Secondary to AMD Using Photodynamic Therapy with Verteporfin for Injection, 2001.

Recent Publications

  • Diabetic Retinopathy Clinical Research Network: Ranibizumab Plus Prompt or Deferred Laser for Diabetic Macular Edema in Eyes with Vitrectomy Before Anti-vascular Endothelial Growth Factor Retina, December 2015-Volume 35-Issue 12-p-2516-2528.
  • Ahmad M Mansour, Maha Shahin, Peter K Kofoed, Maurizio B Parodi, Shami M, Stephen G Schwartz, Collaborative Anti-VEGF Ocular Vascular Complications Group: Insight into 144 Patients with Ocular Vascular Events During VEGF Antagonist I Clinical Ophthalmology, 2012:6 343-363.
  • Diabetic Retinopathy Clinical Research Network: Expanded 2-year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology 2011 Apr;118(4):609-14.
  • Diabetic Retinopathy Clinical Research Network: Rationale for the Diabetic Retinopathy Clinical Research Network Treatment Protocol for Center-involved Diabetic Macular Ophthalmology 2011 Dec;118(12):e5-14.
  • Diabetic Retinopathy Clinical Research Network: Randomized Trial Evaluating Short-term Effects of Intravitreal Ranibizumab or Triamcinolone Acetonide on Macular Edema After Focal/Grid Laser for Diabetic Macular Edema in Eyes also Receiving Panretinal P Retina 2011 Jun;31(6):1009-27.
  • Diabetic Retinopathy Clinical Research Network: Factors Associated with Visual Acuity Outcomes After Vitrectomy for Diabetic Macular Retina. 2010 Oct;30(9):1488-95.
  • Diabetic Retinopathy Clinical Research Network: Vitrectomy Outcomes in Eyes with
  • Diabetic Macular Edema and Vitreomacular Traction. Ophthalmology 2010 Jun: 117 (6): 1087-1093.
  • Diabetic Retinopathy Clinical Research Network: Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema. Ophthalmology 2010 Jun: 117 (6): 1064-1077.

Presentations

  • Vitritis in a Healthy 18 y.o. Male: What’s Next. TTUHSC Dept of Ophthlamlogy, 30th Annual Clinical Update for the Comprehensive Ophthalmologist, June 28, 2013.
  • New Paradigm in the treatment of Diabetic Macular edema. TTUHSC Dept of Ophthalmology, November 2010.
  • Fluorescein Conferences and Lectures. Residency Program, Dept of Ophthalmology,TTUHSC 2001- 09.
  • DRCR Net Protocol B and D: Review of Clinical Trial and Results. Beirut, Lebanon, July 2009.
  • Controversies in the Repair of Retinal D Beirut, Lebanon, June 2008.
  • Guidelines for Obtaining Good OCT Scans. Beirut, Lebanon, December 2007.
  • Diurnal Variation in Retinal Thickening Measured by OCT(on behalf of the DRCR net). American Society of Retinal Specialists 24th Annual Meeting September 9-13, 2006, Cannes, France.
  • Proliferative Diabetic Retinopathy. Vitreoretinal Update 2005 for Optometrists. Presbyterian Hospital, Dallas, Texas, April 2005.
  • Intravitreal Kenalog in the Management of Macular Beirut, Lebanon, July 2004.
  • Retinal H Vitreoretinal Update 2004 for Optometrists. Presbyterian Hospital, Dallas, Texas, April 2004.

Other Professional Achievements / Awards

  • Woodward/White, Inc.: The Best Doctors in America, 1998, 2002, 2011, 2012, 2014 Listings.
  • American Academy of Ophthalmology Achievement Award, 2002
  • “America’s Top Ophthalmologist,” listing 2004-2005 Edition
  • Diabetic Retinopathy Clinical Research Network (DRCR net): Best Site Award 2006, Top Site Award 2007.

Community Interests / Involvement

  • Clinical Associate Professor, Department of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, Texas